Clinical Trials Search
Clinical Trial 20733
Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT03150693
Phase: Phase III
Prinicipal Investigator: Fernando Vargas Madueno
Study Title
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzomab Ozogamicin (a conjugated anti-CD22 monoclonal antibody) to Frontline Therapy in Young Adults (ages 18-39 years) with Newly Diagnosed Precusor B-cell ALL
Summary
Objective
Therapies
Medications
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.